In Vitro Efficacy of High-Dose Tobramycin against Burkholderia cepacia Complex and Stenotrophomonas maltophilia Isolates from Cystic Fibrosis Patients

Burkholderia cepacia complex and Stenotrophomonas maltophilia infections are associated with poor clinical outcomes in persons with cystic fibrosis (CF). The MIC(50) based on planktonic growth and the biofilm concentration at which 50% of the isolates tested are inhibited (BIC(50)) of tobramycin wer...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antimicrob Agents Chemother
Autori principali: Ratjen, Anina, Yau, Yvonne, Wettlaufer, Jillian, Matukas, Larissa, Zlosnik, James E. A., Speert, David P., LiPuma, John J., Tullis, Elizabeth, Waters, Valerie
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2014
Soggetti:
Susceptibility
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4291427/
https://ncbi.nlm.nih.gov/pubmed/25348526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04123-14
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi